Hantaan Virus RNA Load in patients having hemorrhagic fever with renal syndrome: Correlation with disease severity

Journal of Infectious Diseases

Volumn 207, Issue 9, 2013, Pages 1457-1461

  Yi, Jing ^a,b   Xu, Zhuwei ^a   Zhuang, Ran ^a   Wang, Jiuping ^c   Zhang, Yusi ^a   Ma, Ying ^a   Liu, Bei ^a   Zhang, Yun ^a   Zhang, Chunmei ^a   Yan, Guolin ^a   Zhang, Fanglin ^a   Xu, Zhikai ^a   Yang, Angang ^a   Jin, Boquan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hantaan virus; hemorrhagic fever with renal syndrome; viral load

Indexed keywords

VIRUS RNA;

ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; HANTAVIRUS INFECTION; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD; VIRUS RNA LOAD;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; FEMALE; HANTAAN VIRUS; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; MALE; MIDDLE AGED; PLASMA; RNA, VIRAL; SEVERITY OF ILLNESS INDEX; VIRAL LOAD; YOUNG ADULT;

EID: 84876011261     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis475     Document Type: Article

References (13)

1. Meyer BJ, Schmaljohn CS. Persistent hantavirus infections: characteristics and mechanisms. Trends Microbiol 2000; 8:61-7. (Pubitemid 30100328)
2. Linderholm M, Elgh F. Clinical characteristics of hantavirus infections on the Eurasian continent. Curr Top Microbiol Immunol 2001; 256:135-51.
3. Khaiboullina SF, Morzunov SP, St Jeor SC. Hantaviruses: molecular biology, evolution and pathogenesis. Curr Mol Med 2005; 5:773-90. (Pubitemid 43009517)
4. Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev 2010; 23:412-41.
5. Terajima M, Hendershot JD 3rd, Kariwa H, et al. High levels of viremia in patients with the Hantavirus pulmonary syndrome. J Infect Dis 1999; 180:2030-4.
6. Xiao R, Yang S, Koster F, Ye C, Stidley C, Hjelle B. Sin Nombre viral RNA load in patients with hantavirus cardiopulmonary syndrome. J Infect Dis 2006; 194:1403-9. (Pubitemid 44706509)
7. Saksida A, Duh D, Korva M, Avsic-Zupanc T. Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis 2008; 197:681-5. (Pubitemid 351364467)
8. Xu Z, Wei L, Wang L, Wang H, Jiang S. The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization. Biochem Biophys Res Commun 2002; 298:552-8. (Pubitemid 35333693)
9. Liang M, Mahler M, Koch J, et al. Generation of an HFRS patientderived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain. J Med Virol 2003; 69:99-107. (Pubitemid 35403660)
10. Koch J, Liang M, Queitsch I, Kraus AA, Bautz EK. Human recombinant neutralizing antibodies against hantaan virus G2 protein. Virology 2003; 308:64-73. (Pubitemid 36428965)
11. Wang M, Wang J, Zhu Y, et al. Cellular immune response to Hantaan virus nucleocapsid protein in the acute phase of hemorrhagic fever with renal syndrome: correlation with disease severity. J Infect Dis 2009; 199:188-95.
12. Terajima M, Ennis FA. T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome. Viruses 2011; 3:1059-73.
13. Evander M, Eriksson I, Pettersson L, et al. Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol 2007; 45:2491-7. (Pubitemid 47295479)